Intrinsic Value of S&P & Nasdaq Contact Us

Replimune Group, Inc. REPL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
51/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.75
+605.1%

Replimune Group, Inc. (REPL) has a consensus analyst rating of Buy, based on 15 analysts covering the stock. Of those, 12 recommend buying, 3 recommend holding, and 0 recommend selling.

The analyst consensus price target for REPL is $13.75, representing a +605.1% upside from the current price of $1.95. Price targets range from a low of $11.00 to a high of $18.00.

Analyst Consensus — REPL

Buy
Strong Buy
0
Buy
12
Hold
3
Sell
0
Strong Sell
0
15 analysts
Price Targets
Consensus$13.75
High$18.00
Low$11.00
Median$13.00
Last Month Avg-
Last Quarter Avg$14.00
Last Year Avg$13.75
All-Time Count15
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message